VAXNEUVANCE 4 ug/.5mL

VAXNEUVANCE 4 ug/.5mL is a pneumococcal 15-valent conjugate vaccine designed for immunization. This injection helps protect against pneumococcal diseases caused by 15 serotypes.

VAXNEUVANCE 4 ug/.5mL is used for the prevention of invasive pneumococcal diseases. This vaccine is administered to help the body build immunity against specific strains of pneumococcal bacteria. It is commonly recommended for individuals who are at higher risk of pneumococcal infections, including young children and adults with certain medical conditions.

Common effects of VAXNEUVANCE 4 ug/.5mL may include mild redness, swelling, or pain at the injection site. Some individuals might experience temporary fever, fatigue, or muscle aches following vaccination. These effects are generally mild and short-lived.

VAXNEUVANCE 4 ug/.5mL should be administered by a healthcare professional. It is important to inform your healthcare provider about any allergies or medical conditions before receiving the vaccine. Always follow the storage and handling instructions provided to maintain the vaccine's efficacy.

VAXNEUVANCE 4 ug/.5mL may interact with certain medications or other vaccines. It is advisable to discuss any ongoing treatments or recent vaccinations with your healthcare provider to ensure safe administration. Avoid taking any other medications or vaccines without consulting a healthcare professional.